Literature DB >> 8980395

Acceleration of MRP-associated efflux of rhodamine 123 by genistein and related compounds.

C H Versantvoort1, T Rhodes, P R Twentyman.   

Abstract

Multidrug resistance (MDR), caused by overexpression of either P-glycoprotein or the multidrug resistance protein (MRP), is characterised by a decreased cellular drug accumulation due to an enhanced drug efflux. In this study, we examined the effects of genistein and structurally related (iso)flavonoids on the transport of rhodamine 123 (Rh123) and daunorubicin in the MRP-overexpressing MDR lung cancer cell lines COR-L23/R and MOR/R. Genistein, genistin, daidzein and quercetin showed major differences in effects on Rh123 vs daunorubicin transport in the MRP-mediated MDR cell lines: the accumulation of daunorubicin was increased, whereas the accumulation of Rh123 was decreased by the flavonoids. The depolarisation of the membrane potential caused by genistein might be involved in the acceleration of the efflux of Rh123 measured in the MRP-overexpressing cell lines. These observations should be taken into account when using fluorescent dyes as probes for determination of transporter activity as a measure of MDR.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8980395      PMCID: PMC2074826          DOI: 10.1038/bjc.1996.658

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

Review 1.  Biochemistry of multidrug resistance mediated by the multidrug transporter.

Authors:  M M Gottesman; I Pastan
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

2.  Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells.

Authors:  P M Chaudhary; I B Roninson
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

3.  Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport.

Authors:  M Müller; C Meijer; G J Zaman; P Borst; R J Scheper; N H Mulder; E G de Vries; P L Jansen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

4.  Chemosensitisation and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein.

Authors:  M A Barrand; T Rhodes; M S Center; P R Twentyman
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

5.  A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes.

Authors:  P R Twentyman; T Rhodes; S Rayner
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

6.  Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-beta-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia.

Authors:  G J Schuurhuis; H J Broxterman; G J Ossenkoppele; J P Baak; C A Eekman; C M Kuiper; N Feller; T H van Heijningen; E Klumper; R Pieters
Journal:  Clin Cancer Res       Date:  1995-01       Impact factor: 12.531

7.  Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.

Authors:  S P Cole; G Bhardwaj; J H Gerlach; J E Mackie; C E Grant; K C Almquist; A J Stewart; E U Kurz; A M Duncan; R G Deeley
Journal:  Science       Date:  1992-12-04       Impact factor: 47.728

8.  Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells.

Authors:  P R Twentyman; N E Fox; K A Wright; N M Bleehen
Journal:  Br J Cancer       Date:  1986-04       Impact factor: 7.640

9.  Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells.

Authors:  C H Versantvoort; G J Schuurhuis; H M Pinedo; C A Eekman; C M Kuiper; J Lankelma; H J Broxterman
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

10.  Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein.

Authors:  C H Versantvoort; H J Broxterman; T Bagrij; R J Scheper; P R Twentyman
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

View more
  2 in total

1.  Secondary Metabolites from Plants Inhibiting ABC Transporters and Reversing Resistance of Cancer Cells and Microbes to Cytotoxic and Antimicrobial Agents.

Authors:  Michael Wink; Mohamed L Ashour; Mahmoud Zaki El-Readi
Journal:  Front Microbiol       Date:  2012-04-23       Impact factor: 5.640

2.  Synergistic cytotoxicity of bcl-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small-cell lung cancer cell lines.

Authors:  U Zangemeister-Wittke; T Schenker; G H Luedke; R A Stahel
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.